Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
32
KD Quote, Financials, Valuation and Earnings
Last price:
$25.22
Seasonality move
:
-9.93%
Day range:
$25.16 - $27.03
52-week range:
$23.28 - $44.20
Dividend yield:
0%
P/E ratio:
14.86x
P/S ratio:
0.40x
P/B ratio:
4.70x
Volume:
3.2M
Avg. volume:
1.9M
1-year change:
-34.25%
Market cap:
$5.8B
Revenue:
$15.1B
EPS (TTM):
$1.70
Earnings Data
Next earnings date for KD
Feb 03
2026
Most recent earnings per share
$0.29
Missed by $0.07
(Nov 4/2025)
Consensus Estimate
$0.36
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $4.2B | -- | -- | $0.93 | -- |
| 02/03/2026 | Q4 | $3.9B | -- | -- | $0.64 | -- |
| 11/04/2025 | Q3 | $3.8B | $3.7B | $0.29 | $0.36 | -$0.07 |
| 08/04/2025 | Q2 | $3.8B | $3.7B | $0.23 | $0.36 | -$0.13 |
| 05/07/2025 | Q1 | $3.8B | $3.8B | $0.28 | $0.51 | -$0.22 |
| 02/03/2025 | Q4 | $3.8B | $3.7B | $0.89 | $0.41 | $0.49 |
| 11/06/2024 | Q3 | $3.7B | $3.8B | -$0.19 | -$0.03 | -$0.16 |
| 07/31/2024 | Q2 | $3.8B | $3.7B | $0.05 | $0.17 | -$0.13 |
| 05/07/2024 | Q1 | $3.8B | $3.9B | -$0.20 | -$0.07 | -$0.12 |
| 02/07/2024 | Q4 | $3.9B | $3.9B | -$0.05 | $0.19 | -$0.24 |
| 11/07/2023 | Q3 | -- | $4.1B | -$0.62 | -- | -- |
| 08/07/2023 | Q2 | -- | $4.2B | -$0.62 | -- | -- |
| 05/16/2023 | Q1 | -- | $4.3B | -$3.24 | -- | -- |
| 02/07/2023 | Q4 | -- | $4.3B | -$0.47 | -- | -- |
| 11/02/2022 | Q3 | -- | $4.2B | -$1.24 | -- | -- |
| 08/03/2022 | Q2 | -- | $4.3B | -$1.11 | -- | -- |
| 05/04/2022 | Q1 | -- | $4.4B | -$1.02 | -- | -- |
| 02/28/2022 | Q4 | -- | $4.6B | -$3.30 | -- | -- |
| 11/22/2021 | Q3 | -- | $4.6B | -$3.09 | -- | -- |
| 06/30/2021 | Q2 | -- | $4.8B | -$1.76 | -- | -- |
| 03/31/2021 | Q1 | -- | $4.8B | -$2.20 | -- | -- |
| 12/31/2020 | Q4 | -- | $4.9B | -$3.21 | -- | -- |
| 09/30/2020 | Q3 | -- | $4.9B | -$1.06 | -- | -- |
| 06/30/2020 | Q2 | -- | $4.7B | -$1.67 | -- | -- |
| 03/31/2020 | Q1 | -- | $4.8B | -$3.05 | -- | -- |
Kyndryl Holdings, Inc. Earnings Questions
-
How Much did Kyndryl Holdings, Inc. Generate in Revenue Last Quarter?
Kyndryl Holdings, Inc. reported $3.7B worth of top line sales in its most recent quarter.
-
Did Kyndryl Holdings, Inc. Beat Earnings Last Quarter?
Kyndryl Holdings, Inc. announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.36 per share.
-
Is Kyndryl Holdings, Inc. Profitable?
Kyndryl Holdings, Inc. reported $802M that represents $3.40 per share over the last quarter.
-
What is the Analyst Consensus for Kyndryl Holdings, Inc. EPS Next Year?
Kyndryl Holdings, Inc.'s earnings are forecast to grow from $1.05 per share to $2.32 per share next year representing an increase of 120.35%.
-
When is Kyndryl Holdings, Inc.'s Earnings Date?
Kyndryl Holdings, Inc.'s next earnings date is February 3, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
